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doi:10.1016/j.jfma.2011.06.017Background/Purpose: Most reports about oculopharyngeal muscular dystrophy (OPMD) have
been contributed by occidental countries, and most of the victims of this disease are racially
white. In contrast, this disorder is rarely seen in Asians and has only one African report. Conse-
quently, OPMD has been regarded as a disease of the Western world. The purpose of this paper
is to challenge the accuracy of this concept.
Methods: In a Chinese immigrant family, 3 patients manifesting signs related to OPMD were
examined. Electromyography, nerve conduction studies, muscle biopsy and genetic analysis
were performed on the proband. All the 322 papers about OPMD were reviewed and their
country of origin was labeled to perceive the approximate prevalence of OPMD. Countries were
categorized into groups according to the continents to which they belonged.
Results: The proband’s muscle histopathology showed small angulated fiber with rimmed vacu-
oles, ultrastructural pathology exposed filamentous intranuclear inclusions, and genetic anal-
ysis of the polyadenylate binding protein nuclear 1(PABPN1) gene revealed 13 GCG
trinucleotide repeats in one allele (GCG)13 while being normal in the other. The survey of
the country of origin of OPMD reports showed that 80% of these papers were contributed by
occidental countries and that the number of publications of OPMD among countries of Amer-
icas and Asia were unequal, when compared to those of European countries, which were fairly
proportioned. An epidemiologic review of the literature is presented and the prevalence of
OPMD is discussed.
Conclusion: This is a China-born Chinese patient with both morphologically and genetically
proven of OPMD. The very low OPMD report rate in developing countries of East Asia is dueChang Gung Memorial Hospital, 222 Mei-King Road, Keelung 20448, Taiwan.
mh.org.tw.
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398 Y.-Y. Chiento the unfamiliarity of medical workers to OPMD and the unavailability of medical supplies to
confirm the diagnosis. In addition, the present and previous reports provide clear evidence
that OPMD in these areas is underdiagnosed.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
OPMD is a late onset disorder of muscle; it is associated
with progressive eyelid ptosis, dysarthria, dysphagia and
proximal weakness.1,2 The cardinal pathologic findings of
OPMD are the presence of distinctive muscle fibers
containing rimmed-vacuoles under a light microscope
(LM) and of unique myocyte nuclei containing
tubulofilamentous-inclusion under an electron microscope
(EM).3 This disorder can be transmitted as both autosomal
dominant and recessive trait; mutations in the
polyadenylate-binding protein nuclear 1 (PABPN1) gene
have been incriminated.4,5 In 1915, Taylor first reported
a French-Canadian family of progressive dysphagia with
ptosis.6 In 1962, Victor et al first introduced the term
oculopharyngeal muscular dystrophy to describe the same
disorder of a North American Jewish family of eastern
European origin.7 Subsequently, OPMD was reported
worldwide; however, the frequency of this disease varies
considerably from area to area. For instance, the preva-
lence of OPMD ranges from 0.5 to 1/100,000 population in
European countries8 and reaches 100/100,000 French
Canadians in Quebec.9 Likewise, the world’s highest gene
frequency of OPMD, which reaches 1/600 population, was
found in Israel’s Bukharan Jews emigrating from central
Asia.10 In contrast, the incidence of OPMD may be lower,
or rather underestimated, among Asian and African
ethnicities than among Caucasian, as only a few reports
have been published.11,12
This paper reports a male patient, emigrating from the
southeastern part of China and settling down in southern
Taiwan in 1949, who had progressive proximal weakness,
ptosis, and dysphagia. Two of his daughters also had
weakness and dysphagia. The pattern of inheritance, age of
onset, muscle pathology findings, and the result of genetic
analysis are compatible with those seen in OPMD. This is
a China-born Chinese patient with genetically and patho-
logically proven OPMD.Figure 1 Family Pedigree. Arrow indicates proband (PT1),
PT2Z patient 2, PT3Z patient 3. Symbols represent the
following: numberZ age, squareZmale, circleZ female,
square/circle filled with colorZ affected with dysphagia or
ptosis.Patients and methods
We examined 3 affected patients in a Chinese immigrant
family shown in Fig. 1. All had mild proximal weakness and
dysphagia. Electromyography (EMG), nerve conduction
studies (NCS) and open muscle biopsies were performed in
the proband (patient 1). Serial frozen sections were stained
with H&E, modified Gomori trichrome and a battery of
histochemical methods. The specimens for EM were fixed in
2% glutaraldehyde for 2 hours and then processed for
embedding in epon. Semithin epon sections for LM were
stained with toluidine blue, and ultrathin epon sections for
EM were stained with uranly acetate and lead citrate.DNA studies
Genomic DNA was extracted from white blood cells. The
GCN repeat region of the PABPN1 gene was amplified by
a PCR method provided by Brais et al13 and modified by
Minami et al.14 The PCR product was subjected to ABI 310
Genetic Analyzer (Applied Biosystems, Carlsbad, California
USA), and the fragment size in the base pair was analyzed
by GeneScan software. GCN repeat size was determined by
comparing the fragment size between the subjected
patient and a series of reference samples in which precise
GCN repeat sizes had already known by sequence analysis.Review of the literature with focus on patients’ or
first authors’ country of origin
A total of 340 English papers about OPMD were obtained by
using the PubMed search engine after entering the term
“oculopharyngeal muscular dystrophy”. Being obviously
irrelevant to the human OPMD, 18 of these 340 papers were
excluded. The remaining 322 papers were categorized
according to the patients’ country of origin or the first
author’s if the patient’s information was not available.
Horizontal stacked bar charts were drawn, with the
length of each bar being proportioned to the number of
paper the country published. Countries are categorized into
groups according to the continent to which it belonged.
Data were further expressed by the number of papers/10
million population of the country.
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Clinical manifestations and pathologic features
All three patients of the proband’s family had mild proximal
weakness and mild dysphagia. The oldest patient, the
proband, had ptosis. According to the proband’s statement,
his elder brother who remained in China, also had ptosis,
dysphagia and weakness, but the medical history of the
proband’s birth parents were not available. Two of the
proband’s daughters, patients 2 and 3, now aged 46 and 38
years old, had only mild proximal weakness and mild
dysphagia, but no ptosis (Fig. 1). The disorder appears to be
inherited through an autosomal dominant trait.
Patient 1 (the proband)
The proband was a 67-year-old male, the third of three
siblings, who developed bilateral ptosis with no diurnal
variation or diplopia at the age of 58 years. To compensate
ptosis, he contracted the frontalis muscle and tilted the
head backward (Fig. 2). Almost at the same time, he also
suffered from episodic choking once or twice a week, with
nasal regurgitation of food; this led to an endoscopic exam,
but no remarkable findings were obtained. He did not lose
weight. On manual muscle testing at the age of 62 years, he
had only mild proximal weakness. Tendon reflexes were
symmetrically normal and the plantar responses were
flexor. He had neither cataracts nor retinal degeneration.
His serum CK level was normal and cardiac evaluation
showed no abnormality. Motor/sensory nerve conduction
velocity and F-wave latencies were normal. The EMG
studies of limb muscles showed a myopathic change, with
slightly increased numbers of small polyphasic potentials in
the abductor pollicis brevis, triceps brachii and paraspinal
muscles at C6, T4 and L5 levels. There was no spontaneous
activity in all examined muscles.
He had a biopsy of the left biceps brachii at 62 years of
age. In transverse sections of frozen specimens, there was
mild variation in fiber size measuring from 5 to 80 mm in
diameter (averageZ 60 mm). No group atrophy, increase in
number of internal nuclei, large centrally placed nuclei,
pyknotic nuclear clumps, fiber splitting, necrotic fiber,Figure 2 Photographs of the proband showing characteristic fa
wrinkled forehead (2A). Besides contracting the frontalis muscle,
compensate for the limitation of visual field defect due to ptosis (inflammatory response, or fibrosis were recognized. Small
angulated fibers (about 4.9% of muscle fibers) with high
oxidative enzyme activities, scattered throughout the
specimen; some of these fibers contained rimmed vacuoles.
These vacuoles, observed in about 0.12% of muscle fibers,
consisted of irregularly round or polygonal clear spaces
lined by a ring of material which was basophilic with HE
stain and red with modified Gomori trichrome stain (Fig. 3A
and 3B).
In semithin epoxy sections, stained with toluidine blue,
some nuclei appeared lighter than normal; on ultrathin
sections, stained with uranyl acetate and lead citrate,
some of these nuclei filled with filamentous inclusions
(Fig. 4). The other EM findings were nonspecific myopathic
alterations including: (1) myofibrillary degeneration with Z-
line streaming in atrophic fibers; (2) myeloid bodies,
membranous structures, and cell debris in rimmed vacu-
oles; and (3) lipofuscin deposits.
Genetic analysis for the expansion of the trinucleotide
(GCG) repeat at 50 end of the coding region of the PABPN1
gene showed that the PCR products of the size corre-
sponding to (GCN) 10 and (GCN) 13 were detected.
Patient 2
This 46-year-old female, the proband’s daughter and the
first of six siblings, was not aware of any problem until her
father was diagnosed as having OPMD. In the past, she
occasionally experienced nasal regurgitation while eating
meals.
On examination, she was a well-nourished female and all
her trunk and limb muscles were normal except for mild
ptosis. Her deep tendon reflexes were all normal. She did
not receive any laboratory examination.
Patient 3
This 38-year-old female, the proband’s daughter and the
fourth of six siblings, also had mild ptosis; she accepted
only physical examination and her manual muscle testing
was almost identical to that seen in patient 2. She also had
mild dysphagia, which presented as intermittent nasal
regurgitation.ce features of OPMD: bilateral ptosis, raised eyebrows, and
proband tilted his head backward, Hutchinson’s posture, to
2B).
Figure 3 Cryostat sections of proband’s left biceps brachii showing rimmed vacuole (3A) and small angulated fibers (3B).
(A) hematoxylin and eosin; (B) adenosin triphosphatase pH 4.6.
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Approximately 30 countries have published 322 papers
about OPMD thus far (Fig. 5A). Indeed, 80% of these papers
were contributed by occidental countries, and the United
States is the most productive country among them. Like-
wise, German is the most productive country in Europe, and
Japan in Asia. Moreover, the number of publications on this
disease among countries of the Americas and Asia are quite
unequal, when compared to those of European countries.
For instance, publications are mainly concentrated in the
United States and Canada in the Americas, and in Japan,
Israel, and Taiwan15,16 in Asia. However, the publications
among European countries are fairly proportioned, espe-
cially in the western European countries. Fig. 5A illustrates
such a state of disequilibrium. In crude terms, the
concentration of the paper distribution in some way
reflects the prevalence of this disease. This reflection
nevertheless is distorted by many factors, including the
level of medical care and the population of the country. To
minimize these distortions, the number of papers was,
therefore, divided by the population of the corresponding
country. The results again showed that the European
countries have relatively approximate publications/10
million populations (Fig. 5B); in fact, the true prevalenceFigure 4 An electron micrograph from proband’s left biceps
brachii muscle demonstrating tubular filamentous inclusions in
a subsarcolemmal nucleus. BarZ 400 nm.rates in these European countries ranges between 0.5 and
1/100,000 populations. Bu contrast, also in the new stacked
bar chart, Canada and Uruguay become the first two
rankings in the Americas,2,17 and Israel and Sakha in Asia.
All four of these countries have large OPMD clusters. Those
are Canada’s French Canadians in Quebec, who have the
world’s largest cluster of OPMD with a frequency of 1/1000
population; Southern Uruguay’s Canary Islands settlers,
whose ancestors move to Uruguay between 1985 and 1900;
Israel’s Bukhara Jewish, who have the world’s highest gene
frequency with 1/600 population; and the Republic of
Sakha’s Yakut people, who have a frequency of 1/11680
Yakut population, which is 10 to 20 times higher compared
to European populations.8Discussion
This paper reports a China-born Chinese patient who was
confirmed histopathologically, ultrastructurally, and
genetically to have OPMD. With its onset late in life and its
clinical features resembling some common aging disorders,
OPMD is therefore easily neglected in many developing
countries. However, this disorder has been reported from >
30 countries, since Taylor reported typical OPMD victims
from a French-Canadian family in 1915. So far, > 300
English papers about OPMD have been published, and the
occidental countries have contributed over 80% of them
(Fig. 5A). This big difference between eastern and western
countries in terms of paper distribution, leads to the
impression that OPMD is a disease of the western world and
that most of the victims of this disorder are racially white.
However, in 1982, Japan reported a Mongoloid OPMD
family; this is the first oriental paper about OPMD.18
Subsequently, Israel, in 1990, reported a large OPMD
cluster in Bukharan Jews who originated from Central
Asia.19 Lastly, in 2008, located in eastern Siberia, the Sakha
Republic, a federal subject of Russia, was reported to have
a very high OPMD prevalence rate in the Yakut population;
the prevalence rate is 10e20 times higher compared to
European populations.20 Still, the densely populated areas
of Asia, especially China and India having about one third of
the world’s population, contributed only a limited number
of papers about OPMD. This phenomenon is not necessary to
denote that the prevalence rates of OPMD in these areas
Figure 5 Horizontal stacked bar chart showing the world distribution of publication of OPMD. (A) each bar represents the amount
of paper the country published, and the country bars were stacked up according to the continent it belonged; (B) each country bar
represents the amount of paper the country published divided the number of 10 million population the country has.
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has been underdiagnosed there.
The reason why OPMD has been underdiagnosed in the
densely populated areas of Asia is threefold: firstly, OPMD is
a rare disorder not well recognized by medical doctors in
the developing countries of Asia; secondly, developed
countries of these areas, such as Japan and Taiwan, readily
diagnosed and reported cases of OPMD (Fig. 5); and thirdly,
some countries outside China diagnosed and reported
Chinese immigrants to have OPMD, indicating under-
diagnosis of this disease in their motherland.
Although large clusters of victims can be found, OPMD is
so rare, as to be neglected by some popular neurologic text
books. Besides, its cardinal clinical features, ptosis and
dysphagia, are non-specific manifestations; thus, OPMD is
easily misinterpreted as other aging disorders. Further-
more, an exact diagnosis of OPMD can only be made either
by observing tubulofilamentous-inclusion in myocyte nuclei
on EM, or demonstrating abnormal GCG repeat at the 5’ end
of the coding region of PABPN1 gene on genetic analysis.
The crucial diagnostic facilities of OPMD, EM and genetic
analysis, are not widely available in developing countries.
Consequently, the low OPMD report rate in densely popu-
lated areas of Asia may account for the low diagnostic rate
of this disease, rather than the low prevalence rate.
China, which accounts for 20% of the world’s population,
has published only a few pathologically and genetically
confirmed papers about OPMD.21e23 By contrast, Japan and
Taiwan, having a relatively similar ethnic background to
China but far better medical care facilities than China,
have higher OPMD report rates than China. The report rates
of these two countries are quite similar to those of Euro-
pean countries, despite the ethnic differences between
East Asia and Europe (Fig. 5B). In fact, Japan’s OPMD report
rate is even higher than that in the United States, and
Taiwan’s is similar to Spain’s. Both the medical facilities
and the OPMD report rate, are at the same level between
Europe, Japan and Taiwan; thus, the prevalence of OPMD in
East Asia may be higher than previously expected. More-
over, two large OPMD clusters located in places near China,
are Bukhara Jews in Uzbekistan near China’s western
border and Yakut people in the Sakha Republic near China’s
northern border. For these reasons, China’s OPMD preva-
lence rate may be higher than previously expected.
At least three reports contributed by China’s next-door
neighbors, Singapore in 1992,24 Malaya in 2005,25 and
Taiwan (the present report), show clear evidence thatChinese immigrants, originally from southern China, have
OPMD. Despite all of these hard facts, China published only
three papers about OPMD. Thus, it is highly suspected
that OPMD in China, especially in Southern China, is
underdiagnosed.
To sum up, reasons for the very low OPMD report rate in
developing countries of East Asia include the unfamiliarity
of medical workers to this rare disorder, and the unavail-
ability of medical supplies to confirm the diagnosis. In
addition, there is clear evidence indicating that OPMD in
these areas is underdiagnosed.
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